Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal/Bolus Insulin Therapy Comparison in Hospital Ward
NCT00841919Phase 4Completed
- Sponsor
- Cook County Health
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin lispro in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Cook County Health. Primary endpoints: Rate of correct timing of insulin and food administration and Pre and post-prandial glucose levels. Started Dec 2006; status: completed.
02
Drugs
insulin glargineinsulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00841919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841919.